Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ala-Cpn10 in mild to moderate SLE
NCT01838694Phase 2Completed
- Sponsor
- Invion Limited
- Start
- Jul 2013
- Primary completion
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ala-cpn10 in systemic lupus erythematosus (SLE), sponsored by Invion Limited. Started Jul 2013; status: completed.
02
Drugs
ala-cpn10
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01838694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01838694.